Back to search

Article

Validation of the association between MRI and gene signatures in facioscapulohumeral dystrophy muscle: implications for clinical trial design

2023-02-20

Abstract excerpt

<h4>ABSTRACT</h4> Identifying the aberrant expression of DUX4 in skeletal muscle as the cause of facioscapulohumeral dystrophy (FSHD) has led to rational therapeutic development and clinical trials. Several studies support the use of MRI characteristics and the expression of DUX4-regulated genes in muscle biopsies as biomarkers of FSHD disease activity and progression, but reproducibility across studies needs fur...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7d110eda-c468-58e3-a3aa-2057269e3fcb
DOI
10.1101/2023.02.20.529303
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Validation of the association between MRI and gene signatures in facioscapulohumeral dystrophy muscle: implications for clinical trial designDOI 10.1101/2023.02.20.529303
Select a neighboring publication to make it the new centre.